Anti-secretory and anti-proliferative actions of next-generation dual subtype 2 and 5 somatostatin receptor ligands in neuroendocrine tumor models.
Saved in:
| Title: | Anti-secretory and anti-proliferative actions of next-generation dual subtype 2 and 5 somatostatin receptor ligands in neuroendocrine tumor models. |
|---|---|
| Authors: | Fedeli F; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy., Bistika M; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy., Ascione F; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy., Marangelo A; Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany.; Joint Heidelberg-Institute for Diabetes and Cancer (IDC) Translational Diabetes Program, Heidelberg University Hospital, Heidelberg, Germany., Guzzi FL; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy., Schrader J; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Harris AG; Holman Division of Diabetes Endocrinology & Metabolism, New York University (NYU) Langone Medical Center, Grossman School of Medicine, New York University, New York, NY, United States., Pellegata NS; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy. |
| Source: | Frontiers in oncology [Front Oncol] 2026 Feb 27; Vol. 16, pp. 1766563. Date of Electronic Publication: 2026 Feb 27 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41836257 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Anti-secretory and anti-proliferative actions of next-generation dual subtype 2 and 5 somatostatin receptor ligands in neuroendocrine tumor models. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fedeli+F%22">Fedeli F</searchLink>; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Bistika+M%22">Bistika M</searchLink>; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Ascione+F%22">Ascione F</searchLink>; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Marangelo+A%22">Marangelo A</searchLink>; Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany.; Joint Heidelberg-Institute for Diabetes and Cancer (IDC) Translational Diabetes Program, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Guzzi+FL%22">Guzzi FL</searchLink>; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Schrader+J%22">Schrader J</searchLink>; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Harris+AG%22">Harris AG</searchLink>; Holman Division of Diabetes Endocrinology & Metabolism, New York University (NYU) Langone Medical Center, Grossman School of Medicine, New York University, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Pellegata+NS%22">Pellegata NS</searchLink>; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2026 Feb 27; Vol. 16, pp. 1766563. <i>Date of Electronic Publication: </i>2026 Feb 27 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41836257 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2026.1766563 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1766563 Titles: – TitleFull: Anti-secretory and anti-proliferative actions of next-generation dual subtype 2 and 5 somatostatin receptor ligands in neuroendocrine tumor models. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fedeli F – PersonEntity: Name: NameFull: Bistika M – PersonEntity: Name: NameFull: Ascione F – PersonEntity: Name: NameFull: Marangelo A – PersonEntity: Name: NameFull: Guzzi FL – PersonEntity: Name: NameFull: Schrader J – PersonEntity: Name: NameFull: Harris AG – PersonEntity: Name: NameFull: Pellegata NS IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 02 Text: 2026 Feb 27 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 16 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |